HistoSonics Raises $250M Oversubscribed Round to Expand Edison System

Deal Summary

HistoSonics closed an oversubscribed $250M financing to support commercial expansion of its Edison histotripsy system, accelerate clinical indications, and bolster operations. The round was led by the company's new ownership group and included investors such as Thiel Bio and Founders Fund.